GLP-1 receptor agonist therapy is associated with reduced atrial fibrillation recurrence after catheter ablation: a meta-analysis
- 6 January 2026
- journal article
- review article
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (3) , 321-323
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Outcomes of Transvenous Lead Removal in Patients With Prior Mediastinal RadiationJournal of Cardiovascular Electrophysiology, 2025
- Habitual sleep duration and QT variability index: Correlates of ventricular repolarization lability and all-cause mortalityHeart Rhythm, 2025
- Efficacy of semaglutide in reducing atrial fibrillation recurrence post-catheter ablation: propensity score-matched analysisEP Europace, 2025
- Long‐Term Impact of GLP‐1 Receptor Agonists on AF Recurrence After Ablation in Obese PatientsJournal of Cardiovascular Electrophysiology, 2025
- PO-01-030 LONG-TERM ABLATION OUTCOMES IN THE LIRAGLUTIDE EFFECT ON ATRIAL FIBRILLATION (LEAF) STUDYHeart Rhythm, 2025
- Efficacy of balloon-expandable extreme-low-temperature ventricular epicardial cryoablation: A preclinical proof of concept evaluationHeart Rhythm, 2024
- MP-483498-003 SEMAGLUTIDE AND ATRIAL FIBRILLATION RECURRENCE AFTER CATHETER ABLATIONHeart Rhythm, 2024
- PO-05-145 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST IN PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION: A MATCHED ANALYSISHeart Rhythm, 2024
- Comparisons of long-term clinical outcomes with left bundle branch pacing, left ventricular septal pacing, and biventricular pacing for cardiac resynchronization therapyHeart Rhythm, 2024